PTtoPT supply chain homepage banner

At the inaugural Patient-to-Patient Supply for Cell Immunotherapies Summit, this community will gather to share their expertise and propose best practice for seamless vein-to-vein delivery at the clinical and commercial scale.

  • Implement robust, patient-centric supply chains for clinical to commercial readiness
  • Optimize patient care with best practice guidelines and integrated platforms
  • Maintain product quality at scale for seamless delivery of autologous and allogeneic therapies
kirstin powel novartis

“This meeting provides an opportunity to collaborate with colleagues on supply chain topics that are unique to immunotherapies, in the interest of consistently delivering the highest quality products to our patients”

Kirstin Powel, Global Head, External Quality Operations, Novartis Cell 

Join the Patient-to-Patient Supply for Cell Immunotherapies Summit to:

Implement robust, patient-centric supply chains for clinical to commercial readiness

  • Build your supply strategy and manage risk and forecasting at scale by designing for growth
  • Maximize your cloud-based and integrated systems and hear the latest innovations in chain of identity
  • Manage materials, external manufacturing and facility design

Optimize patient care with best practice guidelines and integrated platforms

  • Understand clinical requirements and develop clinical strategies for seamless therapeutic delivery
  • Discuss and establish industry best practices and understand which standard practices can apply across a range of cell modalities

Maintain product quality at scale for seamless delivery of autologous and allogeneic therapies

  • Optimize front-end processes and develop patient care organisations
  • Discuss quality control and site audits to ensure best standard of care and product quality

The Patient-to-Patient Supply for Cell Immunotherapies Summit is your dedicated forum for all things Supply Chain in 2020!

World-Class Speaker Faculty

Hear What Our Speakers Say

al ribickas moffitt

“The challenges that we faced 12 months ago regarding the delivery of these therapies to our patients are now more complicated due to the emergence of COVID 19. I believe that a great exchange of strategies and ideas will benefit our teams, but most importantly our patients. Please join me at the meeting to strategize, share, and shape the future of the delivery of these treatments to our patients”

Albert Ribickas

Supervisor, Cell Therapy Facility, Moffitt Cancer Center

alexandra gomez blurbird

"I believe that passionate patient care is the fuel to become greater at what we do. Join me and other professionals in the industry to recode the norm, strategize, and deliver the results our patients deserve”

Alexandra Gomez

Associate Director Patient Services Operations, bluebird bio

Proud to Partner With

Expertise Partner

Innovation Partners